S

SV Life Sciences

95 employees

SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.

Investor insights

Countries invested in

united states2

Sectors invested in

Biotechnology128
Health Care118
Medical Device63
Medical54
Therapeutics48
Biopharma23
Pharmaceutical22
Health Diagnostics12
Life Science12
Information Technology10
Software8
ophthalmology7
oncology7
Drug Discovery6
Peptide Therapeutics6
Phage Display6
Human antibody discovery6
rare disease6
autoimmune disease6
Collaboration6

Funding rounds participated in

$22M sweet spot round size

Most of their 221 investments are in rounds between $11M and $35M

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Medical Device
Private Equity
Health Care
Healthcare services
Medical Devices
Biopharma
Life Science
Dementia
Venture Capital

Date founded

1993

Investments made

T

Therini Bio, Inc. (formerly MedaRed, Inc.) raised $36M on April 27, 2023

Investors: Sanofi Ventures, The Dementia Discovery Fund, Dolby Family Ventures and SV Life Sciences

P

PayMedix raised $25M on January 25, 2023

Investors: Hexagon AB and SV Life Sciences

P

PULMOCIDE LIMITED raised $52M on December 6, 2022

Investors: 旭化成ファーマ(株), Vivo Capital, JEITO, F-Prime Capital Partners, S.R. One Ltd, Longwood Fund, IP Group plc and SV Life Sciences

A

Alpheus Medical, Inc raised $14M on November 10, 2022

Investors: OrbiMed Advisors, Medtech Convergence Fund and SV Life Sciences

U

Undisclosed raised $125M on September 12, 2022

Investors: S.R. One Ltd, Lightstone Ventures, RA Capital Management, L.P., Atlas Venture and SV Life Sciences

U

Undisclosed raised $18M on June 29, 2022

Investors: IndieBio, SOSV - The Accelerator VC, Baring Private Equity Asia and SV Life Sciences

v

viTToria biotherapeutics raised $10M on June 7, 2022

Investors: Tellus BioVentures, Agent Capital and SV Life Sciences

R

Rondo Therapeutics raised $67M on March 2, 2022

Investors: Novo Holdings, Red Tree Venture Capital and SV Life Sciences

P

Perfuze raised $26M on February 9, 2022

Investors: Seroba-Kernel Ltd (Ireland), EarlyBird Snacks, EQT Life Sciences, Enterprise Ireland and SV Life Sciences

Q

Quell Therapeutics raised $156M on November 29, 2021

Investors: Tekla Capital Management, Syncona Limited, Monashee Investment Management LLC, JEITO, British Patient Capital, Ridgeback Capital Management LLC, Point72 Asset Management and SV Life Sciences

Funding rounds raised

S

SV Life Sciences raised undisclosed on December 20, 2018

Investors: SV Life Sciences

FAQ